These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. COVID-19 vaccine-related presumed allergic reactions and second dose administration by using a two-step graded protocol. Patel GB; Chhiba KD; Chen MM; Guo A; Watts MM; Cullen J; Bochner BS; Grammer LC; Greenberger PA; Saltoun CA; Stevens WW; Kuang FL; Peters AT Allergy Asthma Proc; 2021 Nov; 42(6):515-521. PubMed ID: 34871159 [No Abstract] [Full Text] [Related]
10. Differential Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Profiles After Allergic Reactions to Messenger RNA Coronavirus Disease 2019 Vaccine. Maron JS; Conroy M; Naranbai V; Samarakoon U; Motazedi T; Farmer JR; Freeman E; Banerji A; Bartsch YC; Gregory DJ; Poznansky MC; Alter G; Blumenthal KG J Infect Dis; 2022 Sep; 226(7):1231-1236. PubMed ID: 35325158 [TBL] [Abstract][Full Text] [Related]
11. Biphasic anaphylaxis after first dose of messenger RNA coronavirus disease 2019 vaccine with positive polysorbate 80 skin testing result. Pitlick MM; Park MA; Gonzalez-Estrada A; Chiarella SE Ann Allergy Asthma Immunol; 2021 Oct; 127(4):498-499. PubMed ID: 34343674 [No Abstract] [Full Text] [Related]
12. Delving Into COVID-19 Vaccination-Induced Anaphylaxis: Are mRNA Vaccines Safe in Mast Cell Disorders? Azenha Rama T; Álvarez-Twose I J Investig Allergol Clin Immunol; 2021 Apr; 31(2):193-195. PubMed ID: 33574015 [No Abstract] [Full Text] [Related]
13. Biphasic anaphylaxis after exposure to the first dose of Pfizer-BioNTech COVID-19 mRNA vaccine. Abi Zeid Daou C; Natout MA; El Hadi N J Med Virol; 2021 Oct; 93(10):6027-6029. PubMed ID: 34050949 [TBL] [Abstract][Full Text] [Related]
14. Meta-Analysis of Risk of Myocarditis After Messenger RNA COVID-19 Vaccine. Wang M; Wen W; Zhou M; Wang C; Feng ZH Am J Cardiol; 2022 Mar; 167():155-157. PubMed ID: 35063268 [No Abstract] [Full Text] [Related]
15. Utility and futility of skin testing to address concerns surrounding messenger RNA coronavirus disease 2019 vaccine reactions. Pitlick MM; Sitek AN; D'Netto ME; Dages KN; Chiarella SE; Gonzalez-Estrada A; Joshi AY; Park MA Ann Allergy Asthma Immunol; 2022 Feb; 128(2):153-160. PubMed ID: 34798275 [TBL] [Abstract][Full Text] [Related]
16. Successful mRNA SARS-Cov-2 vaccine rechallenge after a first episode of immune thrombocytopenic purpura. Chanut M; Jaidi R; Kohn M; Grange T; Brones C; Lombion N; Rousselot P; Longval T Platelets; 2022 May; 33(4):652-653. PubMed ID: 35225144 [TBL] [Abstract][Full Text] [Related]
17. Boosting maternal and neonatal humoral immunity following SARS-CoV-2 infection using a single messenger RNA vaccine dose. Nevo L; Cahen-Peretz A; Vorontsov O; Frenkel R; Kabessa M; Cohen SM; Hamrani A; Oiknine-Djian E; Lipschuetz M; Goldman-Wohl D; Walfisch A; Kovo M; Neeman M; Yagel S; Wolf DG; Beharier O Am J Obstet Gynecol; 2022 Sep; 227(3):486.e1-486.e10. PubMed ID: 35430228 [TBL] [Abstract][Full Text] [Related]
18. Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines. Moghimi SM Mol Ther; 2021 Mar; 29(3):898-900. PubMed ID: 33571463 [No Abstract] [Full Text] [Related]